RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,073 | -55.1% | 15,477 | -58.7% | 0.00% | -100.0% |
| Q1 2023 | $84,752 | -40.3% | 37,501 | -7.8% | 0.00% | 0.0% |
| Q4 2022 | $142,008 | -89.1% | 40,690 | +15.8% | 0.00% | -85.7% |
| Q3 2022 | $1,300,000 | +65.6% | 35,125 | -15.0% | 0.01% | +40.0% |
| Q2 2022 | $785,000 | -13.7% | 41,317 | +22.5% | 0.01% | -37.5% |
| Q1 2022 | $910,000 | +4450.0% | 33,731 | +3610.8% | 0.01% | – |
| Q4 2021 | $20,000 | -94.6% | 909 | -93.5% | 0.00% | -100.0% |
| Q3 2021 | $369,000 | +846.2% | 14,060 | +1053.4% | 0.01% | – |
| Q2 2021 | $39,000 | +3800.0% | 1,219 | +4103.4% | 0.00% | – |
| Q1 2021 | $1,000 | -95.0% | 29 | -95.4% | 0.00% | – |
| Q4 2020 | $20,000 | -42.9% | 624 | -33.5% | 0.00% | -100.0% |
| Q3 2020 | $35,000 | – | 938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |